UA90263C2 - COMPOSITIONS COMPRISING DROSPIRENONE MOLECULARLY DISPERSED <http://v3.espacenet.com/publicationDetails/biblio?DB=EPODOC&adjacent=true&locale=ru_ru&FT=D&date=20091224&CC=NZ&NR=549792A&KC=A> - Google Patents
COMPOSITIONS COMPRISING DROSPIRENONE MOLECULARLY DISPERSED <http://v3.espacenet.com/publicationDetails/biblio?DB=EPODOC&adjacent=true&locale=ru_ru&FT=D&date=20091224&CC=NZ&NR=549792A&KC=A>Info
- Publication number
- UA90263C2 UA90263C2 UAA200610358A UAA200610358A UA90263C2 UA 90263 C2 UA90263 C2 UA 90263C2 UA A200610358 A UAA200610358 A UA A200610358A UA A200610358 A UAA200610358 A UA A200610358A UA 90263 C2 UA90263 C2 UA 90263C2
- Authority
- UA
- Ukraine
- Prior art keywords
- compositions
- molecularly dispersed
- publicationdetails
- biblio
- espacenet
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- METQSPRSQINEEU-UHFFFAOYSA-N dihydrospirorenone Natural products CC12CCC(C3(CCC(=O)C=C3C3CC33)C)C3C1C1CC1C21CCC(=O)O1 METQSPRSQINEEU-UHFFFAOYSA-N 0.000 title abstract 2
- METQSPRSQINEEU-HXCATZOESA-N drospirenone Chemical compound C([C@]12[C@H]3C[C@H]3[C@H]3[C@H]4[C@@H]([C@]5(CCC(=O)C=C5[C@@H]5C[C@@H]54)C)CC[C@@]31C)CC(=O)O2 METQSPRSQINEEU-HXCATZOESA-N 0.000 title abstract 2
- 229960004845 drospirenone Drugs 0.000 title abstract 2
- 239000007787 solid Substances 0.000 abstract 2
- 238000004090 dissolution Methods 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000003637 steroidlike Effects 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Otolaryngology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04075713 | 2004-03-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA90263C2 true UA90263C2 (en) | 2010-04-26 |
Family
ID=34928104
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200610358A UA90263C2 (en) | 2004-03-10 | 2005-03-10 | COMPOSITIONS COMPRISING DROSPIRENONE MOLECULARLY DISPERSED <http://v3.espacenet.com/publicationDetails/biblio?DB=EPODOC&adjacent=true&locale=ru_ru&FT=D&date=20091224&CC=NZ&NR=549792A&KC=A> |
Country Status (12)
| Country | Link |
|---|---|
| CN (1) | CN1980636A (sr) |
| AR (1) | AR048002A1 (sr) |
| DE (1) | DE602005022952D1 (sr) |
| GT (1) | GT200500044A (sr) |
| MY (1) | MY143870A (sr) |
| PA (1) | PA8625901A1 (sr) |
| PE (1) | PE20060004A1 (sr) |
| RS (1) | RS50975B (sr) |
| SV (1) | SV2005002043A (sr) |
| TW (2) | TW200840587A (sr) |
| UA (1) | UA90263C2 (sr) |
| UY (1) | UY28802A1 (sr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106109420B (zh) * | 2016-08-11 | 2018-07-06 | 吴启旸 | 依普利酮固体分散体及其制剂 |
-
2005
- 2005-03-09 MY MYPI20050960A patent/MY143870A/en unknown
- 2005-03-10 TW TW097123405A patent/TW200840587A/zh unknown
- 2005-03-10 UA UAA200610358A patent/UA90263C2/ru unknown
- 2005-03-10 PA PA20058625901A patent/PA8625901A1/es unknown
- 2005-03-10 SV SV2005002043A patent/SV2005002043A/es not_active Application Discontinuation
- 2005-03-10 RS RSP-2009/0307A patent/RS50975B/sr unknown
- 2005-03-10 UY UY28802A patent/UY28802A1/es not_active Application Discontinuation
- 2005-03-10 TW TW094107361A patent/TW200609000A/zh unknown
- 2005-03-10 PE PE2005000278A patent/PE20060004A1/es not_active Application Discontinuation
- 2005-03-10 DE DE602005022952T patent/DE602005022952D1/de not_active Expired - Lifetime
- 2005-03-10 CN CNA2005800150652A patent/CN1980636A/zh active Pending
- 2005-03-10 AR ARP050100923A patent/AR048002A1/es unknown
- 2005-03-10 GT GT200500044A patent/GT200500044A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW200609000A (en) | 2006-03-16 |
| DE602005022952D1 (de) | 2010-09-23 |
| SV2005002043A (es) | 2005-11-04 |
| CN1980636A (zh) | 2007-06-13 |
| AR048002A1 (es) | 2006-03-15 |
| PE20060004A1 (es) | 2006-02-16 |
| TW200840587A (en) | 2008-10-16 |
| MY143870A (en) | 2011-07-15 |
| PA8625901A1 (es) | 2006-07-03 |
| GT200500044A (es) | 2005-10-31 |
| UY28802A1 (es) | 2005-10-31 |
| RS50975B (sr) | 2010-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL177893A0 (en) | Compositions comprising drospirenone molecularly dispersed | |
| CR8630A (es) | Solidos supersaturados estabilizados de drogas lipofilicas | |
| TR200001810A2 (tr) | Hemen Eriyen Oral Dozaj Formülasyonu. | |
| IL184758A0 (en) | New pharmaceutical compositions useful in the transmucosal administration of drugs | |
| WO2008033351A3 (en) | Multimodal abuse resistant and extended release formulations | |
| MA37809A1 (fr) | Administration de médicament biodégradable pour compositions hydrophobes | |
| IL162671A0 (en) | Micronized pharmaceutical or nutraceutical powder with immediate release | |
| WO2005004917A3 (en) | Pharmaceutical composition for solubility enhancement of hydrophobic drugs | |
| PL1916994T3 (pl) | Wytwarzanie kompozycji farmaceutycznej o szybkim uwalnianiu leków nierozpuszczalnych w wodzie i kompozycje farmaceutyczne otrzymywane sposobem według wynalazku | |
| WO2008023362A3 (en) | Use of a combination of methotrexate and an a3ar agonist for the treatment of cancer | |
| FR2878158B1 (fr) | Forme pharmaceutique orale, microparticulaire solide concue pour eviter le mesusage | |
| WO2007100382A3 (en) | Orally administrable gallium compositions and method of use | |
| UA90263C2 (en) | COMPOSITIONS COMPRISING DROSPIRENONE MOLECULARLY DISPERSED <http://v3.espacenet.com/publicationDetails/biblio?DB=EPODOC&adjacent=true&locale=ru_ru&FT=D&date=20091224&CC=NZ&NR=549792A&KC=A> | |
| IL179021A (en) | Tetrahydroisoquinoline sulfonamide derivatives, pharmaceutical compositions containing the derivative and the use thereof for the preparation of medicaments | |
| WO2007012479A3 (en) | Benzylpiperazine derivates and their medical use | |
| EP1980255A4 (en) | PHARMACEUTICAL COMPOSITIONS COMPRISING SYNTHETIC STEROID DERIVATIVES SUCH AS TIBOLONE, MINERALS SUCH AS CALCIUM AND ACTIVE METABOLITE OF VITAMIN D (CALCITRIOL) FOR THE PREVENTION AND TREATMENT OF OSTEOPOROSIS AND MENOPAUSE | |
| WO2007086911A3 (en) | Stable nanoparticle formulations | |
| WO2006039268A3 (en) | Pharmaceutical formulations containing vitamin e tpgs molecules that solubilize lipophilic drugs without significant efflux inhibition, and use of such formulations | |
| WO2007135295A3 (fr) | Derives de 2-alcoxy-3,4,5-trihydroxy-alkylamide, leur préparation, compositions les contenant et utilisation | |
| WO2007135293A3 (fr) | 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzazepine, leur préparation, compositions les contenant et utilisation | |
| TNSN08442A1 (en) | 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzothiazepines, the preparation and use thereof, and compositions containing the same | |
| HK1116094A (en) | Manufacturing of quick release pharmaceutical composition of water insoluble drugs and pharmaceutical compositions obtained by the process of the invention | |
| CU20060177A7 (es) | Soluciones sólidas supersaturadas estabilizadas de drogas esteroides | |
| TH135239A (th) | องค์ประกอบทางเภสัชกรรมประเภทของแข็งซึ่งประกอบรวมด้วยแอมโลดิพีนและโลซาร์แทน | |
| TH84342B (th) | สารผสมทางเภสัชกรรมที่ประกอบไปด้วยอิมาตินิปและสารชะลอการปลดปล่อยตัวยา |